Dual Aptamers‐Based SETDB1 PROTACs as Effective Anti‐Tumor Strategies for Breast Cancer (Adv. Sci. 18/2026)
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yanxuan Guo, Yingge Lv, Shuyu Huang, Chang Liu, Yan Ouyang, Bei Lan, Chenghao Xuan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Dual Aptamers‐Based SETDB1 PROTACs as Effective Anti‐Tumor Strategies for Breast Cancer
by: Yanxuan Guo, et al.
Published: (2026)
by: Yanxuan Guo, et al.
Published: (2026)
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
by: Yerim Jin, et al.
Published: (2024)
by: Yerim Jin, et al.
Published: (2024)
Issue Information: (Adv. Sci. 18/2026)
Published: (2026)
Published: (2026)
Advancing Design Strategy of PROTACs for Cancer Therapy
by: Hang Luo, et al.
Published: (2025)
by: Hang Luo, et al.
Published: (2025)
TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition (Adv. Sci. 4/2026)
by: Yanchen Zhang, et al.
Published: (2026)
by: Yanchen Zhang, et al.
Published: (2026)
The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis
by: Yu‐Hsuan Chang, et al.
Published: (2025)
by: Yu‐Hsuan Chang, et al.
Published: (2025)
Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor (Adv. Sci. 38/2024)
by: Giovanni S. Offeddu, et al.
Published: (2024)
by: Giovanni S. Offeddu, et al.
Published: (2024)
A Responsive DNA Hydrogel Containing Poly‐Aptamers as Dual‐Target Inhibitors for Localized Cancer Immunotherapy
by: Rui Zhang, et al.
Published: (2024)
by: Rui Zhang, et al.
Published: (2024)
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer (Adv. Sci. 14/2026)
by: John D. Martin, et al.
Published: (2026)
by: John D. Martin, et al.
Published: (2026)
Plasma DNMT1 Activity for Assessing Tumor Burden and Predicting Neoadjuvant Therapy Response in Breast Cancer (Adv. Sci. 31/2025)
by: Yingran Wang, et al.
Published: (2025)
by: Yingran Wang, et al.
Published: (2025)
Issue Information: (Adv. Sci. 20/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 3/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 28/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 25/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 8/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 22/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 9/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 14/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 30/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 21/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 6/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 19/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 1/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 10/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 7/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 24/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 23/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 27/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 4/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 12/2026)
Published: (2026)
Published: (2026)
Issue Information: (Adv. Sci. 16/2026)
Published: (2026)
Published: (2026)
Reversible Thermotropic Energy‐Transfer Dual‐Mode Luminescence in Perovskite Nanocrystals for Advanced Dynamic Anti‐Counterfeiting Applications
by: Shuyu Tian, et al.
Published: (2025)
by: Shuyu Tian, et al.
Published: (2025)
3D‐Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse (Adv. Sci. 46/2024)
by: Lu Wang, et al.
Published: (2024)
by: Lu Wang, et al.
Published: (2024)
Innovative PDK1‐Degrading PROTACs Transform Cancer Aerobic Glycolysis and Induce Immunogenic Cell Death in Breast Cancer
by: Aohua Deng, et al.
Published: (2025)
by: Aohua Deng, et al.
Published: (2025)
Tumor‐Derived CDC37 Inhibits Antigen Cross‐Presentation in Dendritic Cells and Impairs Anti‐Tumor Immunity in Breast Cancer
by: Ruxin Wang, et al.
Published: (2025)
by: Ruxin Wang, et al.
Published: (2025)
Masthead: (Adv. Sci. 18/2024)
Published: (2024)
Published: (2024)
Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
by: Yuan Fang, et al.
Published: (2024)
by: Yuan Fang, et al.
Published: (2024)
TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells (Adv. Sci. 5/2026)
by: Yunhan Wang, et al.
Published: (2026)
by: Yunhan Wang, et al.
Published: (2026)
Deep Learning‐Powered Scalable Cancer Organ Chip for Cancer Precision Medicine (Adv. Sci. 26/2026)
by: Yu‐Chieh Yuan, et al.
Published: (2026)
by: Yu‐Chieh Yuan, et al.
Published: (2026)
Tumor Microenvironment On‐A‐Chip and Single‐Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression (Adv. Sci. 16/2025)
by: Kalpana Ravi, et al.
Published: (2025)
by: Kalpana Ravi, et al.
Published: (2025)
Similar Items
-
Dual Aptamers‐Based SETDB1 PROTACs as Effective Anti‐Tumor Strategies for Breast Cancer
by: Yanxuan Guo, et al.
Published: (2026) -
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
by: Yerim Jin, et al.
Published: (2024) -
Issue Information: (Adv. Sci. 18/2026)
Published: (2026) -
Advancing Design Strategy of PROTACs for Cancer Therapy
by: Hang Luo, et al.
Published: (2025) -
TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition (Adv. Sci. 4/2026)
by: Yanchen Zhang, et al.
Published: (2026)